Helix Biopharma (HBP) Halted for Volatility
Tweet
Share
E-mail
Helix Biopharma Corp. (NYSE: HBP) halted for volatility.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why SpaceX’s launch economics could keep Starlink ahead of Amazon Leo 12
- Citi sees a buying opportunity in this Japanese tech stock
- Shares of this retailer look “inexpensive” heading into earnings, Citi says
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
